168 related articles for article (PubMed ID: 29600661)
41. [Systematic review on safety of sofren injection].
Que Y; Xie YM; Liao X; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3866-3874. PubMed ID: 28929668
[TBL] [Abstract][Full Text] [Related]
42. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Liu JP
Cochrane Database Syst Rev; 2011 Jun; (6):CD007796. PubMed ID: 21678369
[TBL] [Abstract][Full Text] [Related]
43. [Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases].
Liao X; Yu DD; Xie YM; Zhang YL; He Y; Zhang Y; Liu Y; Yi DH; Wang YY
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2857-2863. PubMed ID: 29139248
[TBL] [Abstract][Full Text] [Related]
44. Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations.
Wang C; Shi QP; Ding F; Jiang XD; Tang W; Yu ML; Cheng JQ
Biomed Pharmacother; 2019 Jan; 109():1523-1531. PubMed ID: 30551404
[TBL] [Abstract][Full Text] [Related]
45. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Li X; Yang G; Liu JP
Cochrane Database Syst Rev; 2013 Oct; (10):CD007796. PubMed ID: 24096743
[TBL] [Abstract][Full Text] [Related]
46. [Effect of Guizhi Fuling capsule and combination of active ingredients on rats with uterine myoma].
Heng QQ; Cao L; Li N; Ding G; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2206-9. PubMed ID: 26552182
[TBL] [Abstract][Full Text] [Related]
47. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials.
Guan J; Yuan S; Wu H; Na R; Wu X; Wang X; Bao S
PLoS One; 2017; 12(3):e0173276. PubMed ID: 28323822
[TBL] [Abstract][Full Text] [Related]
49. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
[TBL] [Abstract][Full Text] [Related]
50. [Auxiliary treatment of HBV correlated hepatic failure by Chinese herbs: a systematic review of randomized controlled trials].
Wang RY; Zhou YF; Fei YT; Sun KW
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1449-56. PubMed ID: 24483102
[TBL] [Abstract][Full Text] [Related]
51. [Study of effective components and molecular mechanism for Guizhi Fuling formula treatment of dysmenorrhea, pelvic inflammatory disease and uterine fibroids].
Ke ZP; Zhang XZ; Ding Y; Cao ZY; Li N; Cao L; Wang TJ; Zhang CF; Ding G; Wang ZZ; Xiao W; Xu XJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):999-1004. PubMed ID: 26226734
[TBL] [Abstract][Full Text] [Related]
52. [Establish research model of post-marketing clinical safety evaluation for Chinese patent medicine].
Zheng WK; Liu Z; Lei X; Tian R; Zheng R; Li N; Ren JT; Du XX; Shang HC
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3693-6. PubMed ID: 26983223
[TBL] [Abstract][Full Text] [Related]
53. Oral traditional Chinese medication for adhesive small bowel obstruction.
Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
[TBL] [Abstract][Full Text] [Related]
54. Intergrated metabonomic study of the effects of Guizhi Fuling capsule intervention on primary dysmenorrheal using RP-UPLC-MS complementary with HILIC-UPLC-MS technique.
Lang L; Meng Z; Sun L; Xiao W; Zhao L; Xiong Z
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28906007
[TBL] [Abstract][Full Text] [Related]
55. Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials.
Lee JY; Jun SA; Hong SS; Ahn YC; Lee DS; Son CG
Phytother Res; 2016 Sep; 30(9):1412-9. PubMed ID: 27196988
[TBL] [Abstract][Full Text] [Related]
56. [Systematic analysis on clinical safety of Shuxuetong injection].
Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
[TBL] [Abstract][Full Text] [Related]
57. [Optimization of extraction conditions for semi-bionic extraction of Guizhi Fuling pill decoction by uniform design].
Li F; Zhang Z; Sun X; Wang W; Ma M
Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2151-6. PubMed ID: 21046751
[TBL] [Abstract][Full Text] [Related]
58. [Effect of guizhi fuling pills on the changes of Ca2+ and amino acids in rats with cerebral ischemia and reperfusion].
Zhang Y; Xie K; Wang Y
Zhongguo Zhong Yao Za Zhi; 1998 Sep; 23(9):558-9, back cover. PubMed ID: 11599393
[TBL] [Abstract][Full Text] [Related]
59. [Incidence rate of adverse reaction/event by Qingkailing injection: a Meta-analysis of single rate].
Ai CL; Xie YM; Li MQ; Wang LX; Liao X
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4770-8. PubMed ID: 27245021
[TBL] [Abstract][Full Text] [Related]
60. Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses.
Khan S; Varricchio A; Ricciardelli C; Yool AJ
Front Oncol; 2022; 12():1015708. PubMed ID: 36727068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
